Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy...
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Longeveron (NASDAQ:LGVN) through any online brokerage.
Other companies in Longeveron’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Longeveron has a consensus price target of $70.00.
The stock price for Longeveron (NASDAQ: LGVN) is $1.71 last updated October 14, 2026 at 6:00 PM EDT.
There are no upcoming dividends for Longeveron.
Longeveron does not have any upcoming earnings scheduled.
There is no upcoming split for Longeveron.
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
